Tutto DSpace

Mostra i principali dati dell'item

Prospective, randomized phase III study comparing two intensified regimens (methotrexate/vinblastine/doxorubicin hydrochloride/cisplatin MVAC versus gemcitabine/cisplatin) in patients with inoperable or recurrent urothelial cancer

dc.creatorBamias, A.en
dc.creatorKaradimou, A.en
dc.creatorLampaki, S.en
dc.creatorAravantinos, G.en
dc.creatorXanthakis, I.en
dc.creatorPapandreou, C.en
dc.creatorLainakis, G.en
dc.creatorZagouri, F.en
dc.creatorSoupos, N.en
dc.creatorKostouros, E.en
dc.creatorSamantas, E.en
dc.creatorHatzimouratidis, C.en
dc.creatorKonstantinidis, C.en
dc.creatorDeliveliotis, C.en
dc.creatorPectasides, D. G.en
dc.creatorFountzilas, G.en
dc.creatorDimopoulos, M. A.en
dc.creatorHellenic Cooperative Oncology, Grpen
dc.date.accessioned2015-11-23T10:23:32Z
dc.date.available2015-11-23T10:23:32Z
dc.date.issued2011
dc.identifier.issn0732-183X
dc.identifier.urihttp://hdl.handle.net/11615/26136
dc.sourceJournal of Clinical Oncologyen
dc.source.uri<Go to ISI>://WOS:000208880300552
dc.subjectOncologyen
dc.titleProspective, randomized phase III study comparing two intensified regimens (methotrexate/vinblastine/doxorubicin hydrochloride/cisplatin MVAC versus gemcitabine/cisplatin) in patients with inoperable or recurrent urothelial canceren
dc.typejournalArticleen


Files in questo item

FilesDimensioneFormatoMostra

Nessun files in questo item.

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item